Fetal death in utero and miscarriage in a patient with Crohn’s disease under therapy with ustekinumab: case-report and review of the literature

Fetal death in utero and miscarriage in a patient with Crohn’s disease under therapy with ustekinumab: case-report and review of the literature

Abstract Background Ustekinumab is a fully human monoclonal antibody against the p40 subunit of interleukin (IL) 12 and 23 which is involved in the pathogenesis of several inflammatory diseases. Ustekinumab is approved for psoriasis and psoriatic arthritis treatment and has been successfully evaluat...

Full description

Bibliographic Details
Main Authors: C. Venturin, S. Nancey, P. Danion, M. Uzzan, M. Chauvenet, C. Bergoin, X. Roblin, B. Flourié, G. Boschetti
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Gastroenterology
Subjects:
Anti-IL12/23
Ustekinumab
Crohn’s disease
Pregnancy
Online Access:http://link.springer.com/article/10.1186/s12876-017-0633-6

Internet

http://link.springer.com/article/10.1186/s12876-017-0633-6

Similar Items